Genomics England appoints Dr Ellen Thomas as Chief Medical Officer
Genomics England is pleased to announce the appointment of Dr Ellen Thomas as its new Chief Medical Officer.
Ellen trained as a clinical geneticist at Guy’s and St Thomas’ NHS Trust, and has worked at Genomics England since 2015, where she has previously held several roles including Interim Chief Medical Officer and Deputy Chief Medical Officer.
At Genomics England she has worked on delivery of the 100,000 Genomes Project, and now leads on Genomics England’s contributions to the NHS Genomic Medicine Service, and on implementation of the ground-breaking Generation Study, as well as supporting the connections between research and clinical care for participants and researchers within the National Genomic Research Library.
“We are delighted to welcome Ellen into her new role; her wealth of experience in genomics and clinical medicine, and her dedication to patient care, will be vital as we continue to deliver on our commitment of advancing genomic research and healthcare innovation. Her leadership and expertise have been instrumental in building our capabilities as an organisation delivering accredited services to the NHS and delivery of ambitious research and innovations programmes working in partnership with the NHS, our participants and researchers to deliver on the promise of genomic healthcare.”
Dr Rich Scott
Chief Executive Officer of Genomics England
"I am honoured to take on the position of Chief Medical Officer at Genomics England. This is an exciting time for genomic medicine, and I look forward to working with our talented team to further our mission of transforming healthcare through genomics. Together, we will strive to make genomic medicine ever more accessible and beneficial for a wider group of patients."
Dr Ellen Thomas
Chief Medical Officer of Genomics England
Ellen holds a medical degree from the University of Cambridge and has completed advanced training in clinical genetics. She studied for a PhD at Imperial College, using early high-throughput sequencing technology to investigate genetic contributions to adult-onset genomic conditions.
She is widely recognised for her contributions to the field of genomics and has published numerous research papers on the subject. Her visionary approach and dedication to the integration of genomics in healthcare make her a highly respected leader in the medical community.
